3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
7
Oropharyngeal Neoplasms
5
Lung Neoplasms
5
Mouth Neoplasms
4
Mesothelioma, Malignant
4
Laryngeal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Nasopharyngeal Carcinoma
3
Lymphoid Interstitial Pneumonia
3
Hypopharyngeal Neoplasms
3
Uterine Cervical Neoplasms
2
Pancreatic Neoplasms
2
Ganglioneuroblastoma
2
Cholangiocarcinoma
2
Adenocarcinoma of Lung
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Triple Negative Breast Neoplasms
1
Tongue Neoplasms
1
Solitary Fibrous Tumor, Pleural
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Salivary Gland Neoplasms
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Interventions
pembrolizumab
2
tislelizumab
1
sacituzumab govitecan
1
fludarabine
1
SYS6006 COVID-19 vaccine
1
Pemetrexed
1
Oxaliplatin
1
Leucovorin
1
Fluorouracil
1
Drug Therapy
1
Cetuximab
1
Carboplatin
1
Antiemetics
1
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
Platinum
×
30 days
×
Clear all
No trials found.